Biohaven stock tumbled for the second day running Tuesday after its bipolar mania treatment failed in a three-week study.

Illumina stock slid on Tuesday after China banned imports of the biotech’s gene sequencing machines as part of a broader ...

The Financial Times is reporting that Walgreens Boots Alliance would be split three ways if Sycamore Partners buys out the ...

Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that Abeona’s Chief Executive Officer, Vish Seshadri, Ph.D., M.B.A., ...

Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven clinical and pre-clinical brain disease programs, today announced ...

A live webcast link for the Leerink Partners Global Biopharma Conference fireside chat will be available at https://investors.werewolftx.com/news-and-events/events. An archived replay will be ...

Equities research analysts at Leerink Partnrs issued their FY2026 EPS estimates for Kura Oncology in a note issued to investors on Wednesday, February 26th. Leerink Partnrs analyst J. Chang ...

Equities research analysts at Leerink Partnrs issued their Q1 2025 earnings estimates for Intellia Therapeutics in a research report issued to clients and investors on Thursday, February 27th. Leerink ...

Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical analysis, today announced ...

The webcast of the fireside chat will be accessible in the investor section of 89bio’s website. A replay of the webcast will be available for approximately 30 days following the conference.

Leerink Partners and Piper Sandler are acting as joint bookrunning managers for the proposed offering.

Savara Inc. (Nasdaq: SVRA ) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that members of its management team will attend the Leerink ...